Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.4 EUR | +1.69% | +1.69% | +29.03% |
04-03 | Vytrus Biotech, S.A. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
2023 | Vytrus Biotech, S.A. Reports Earnings Results for the Half Year Ended June 30, 2023 | CI |
Sales 2024 * | 4.58M 4.92M 394M | Sales 2025 * | - | Capitalization | 16.16M 17.37M 1.39B |
---|---|---|---|---|---|
Net income 2024 * | - | Net income 2025 * | - | EV / Sales 2024 * | 3.76 x |
Net Debt 2024 * | 1.03M 1.11M 88.85M | Net cash position 2025 * | - 0 0 | EV / Sales 2025 * | - |
P/E ratio 2024 * |
21.8
x | P/E ratio 2025 * |
-
| Employees | 35 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 31.36% |
1 day | +1.69% | ||
1 week | +1.69% | ||
Current month | +1.69% | ||
1 month | +7.14% | ||
3 months | +16.50% | ||
6 months | +13.21% | ||
Current year | +29.03% |
Managers | Title | Age | Since |
---|---|---|---|
Albert Jané Font
CEO | Chief Executive Officer | - | 31/12/08 |
Chief Executive Officer | - | 31/12/08 | |
Director of Finance/CFO | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | - | 31/12/08 | |
Albert Jané Font
CEO | Chief Executive Officer | - | 31/12/08 |
Director/Board Member | - | - |
Date | Price | Change | Volume |
---|---|---|---|
08/05/24 | 2.4 | +1.69% | 2,462 |
07/05/24 | 2.36 | 0.00% | 0 |
06/05/24 | 2.36 | 0.00% | 0 |
03/05/24 | 2.36 | 0.00% | 36 |
02/05/24 | 2.36 | 0.00% | 9,000 |
Delayed Quote BME, May 08, 2024 at 03:00 pm
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+29.03% | 17.13M | |
-24.82% | 233M | |
-26.78% | 64.76M |
- Stock Market
- Equities
- VYT Stock